Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
Wenzhe Fan(Chongqing Normal University), Jiaping Li(Sun Yat-sen University), Wanchang Huang(First People's Hospital of Nanning), Yanqin Wu(Fujian Medical University), Yue Zhao(Sun Yat-sen University), Bowen Zhu(Sun Yat-sen University), Huishuang Fan(Dongguan People’s Hospital), Hongyu Wang(Fifth Affiliated Hospital of Zhengzhou University), Yu Wang(Sun Yat-sen University), Jian Guo(Nanjing Medical University), Fuliang Li(Gaozhou People's Hospital), Lei Yu(Taiyuan Central Hospital), Miao Xue(Sun Yat-sen University), Shutong Wang(Sun Yat-sen University)
Cited by 27
Related Papers
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
|Signal Transduction and Targeted Therapy|2023|295
Macroporous Biphasic Calcium Phosphate Scaffold with High Permeability/Porosity Ratio
|Tissue Engineering|2003|212